Bio Break: Drug-Device Combination Products

Resources

Bio Break: Drug-Device Combination Products

Topic: Bio Break

In this episode of Bio Break, Joris and Nick explore the increasingly important world of drug-device combination products, discussing what they are, why they matter, and the unique challenges associated with their development. As modern pharmaceuticals become more complex, the role of engineered medical devices in delivering these therapies safely and effectively has never been more critical.

Joris begins by defining combination products as therapeutic solutions that combine a medical device with a pharmaceutical under a single regulatory umbrella. He explains why this approach, while more complex, is necessary for modern biologics, such as gene therapies, which require precise delivery to specific parts of the body—like the brain—where traditional methods fall short.

Key takeaways from the episode include:

  • Why Combine Drugs and Devices?: Combination products are often essential for biologics and viscous therapies, which require bespoke devices for controlled, targeted delivery. For example, wearable injectors allow patients to administer viscous drugs over long periods without discomfort or traditional syringes.
  • Regulatory Challenges: Combining a device and a drug introduces additional regulatory considerations, particularly aligning medical device development timelines with pharmaceutical clinical trial phases. Joris highlights how phase one trials often use off-the-shelf devices, but by phase two, the bespoke medical device must be integrated to validate both the drug and the device’s safety and efficacy.
  • Device Engineering for Precision Delivery: Nick illustrates the need for tailored devices that can handle challenges like viscous fluids, using honey as a relatable example. Such precision-engineered devices ensure therapies are delivered effectively, making the drug and device interdependent for success.

The conversation highlights how collaboration between pharmaceutical and medical device developers is critical to meeting clinical milestones and achieving regulatory approval.

This episode is essential viewing for developers, innovators, and healthcare professionals working on combination products. Discover how pairing medical devices with pharmaceuticals enables groundbreaking therapies and unlocks new possibilities for patient care.

Drug-Device Combination Products – Navigating Complexity

YouTube video thumbnail
A medical professional wearing a white coat and blue gloves holds a red cooler labeled ‘Organ Transport.’ Overlay text reads: ‘The call came’ in bold black letters on a white highlight.

In this Before the Build episode, Eric Olson and Paul Charlebois dive into the importance of organ transplant logistics when designing effective medical devices.

A vial of orange liquid with a radiation symbol and a syringe sit on a reflective metal surface in front of a large medical imaging machine. The overlay text reads: "Radioactive. On Purpose?" in bold black font on a white rounded background.

Radiopharmaceutical device development is gaining momentum as medical teams explore new frontiers in diagnostic imaging and cancer treatment.

Surgeon practicing on a surgical simulator during a medical training session in a clinical environment

The simplest and least expensive way to train users of medical devices is to ask them study the Instructions for Use (IFU) beforehand.

An iron lung on the left and a modern medical ventilator on the right, shown against a plain white background. A red arrow points from the iron lung to the ventilator. Bold overlay text reads: ‘Then vs. Now’ in white font on a black background.

In this MedDevice by Design episode, Ariana Wilson and Mark Drlik take us back in time to explore iron lung innovation during the polio epidemic of the 1920s.